Reactions Weekly

, Volume 1633, Issue 1, pp 563–563 | Cite as

Nivolumab

Various toxicities: case report
Case report
  • 30 Downloads

Reference

  1. Ascierto PA, et al. Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial. Cancer Immunology Immunotherapy 65: 1395-1400, No. 11, Nov 2016. Available from: URL: http://doi.org/10.1007/s00262-016-1898-2 - ItalyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations